Andrzej Dymek

466 total citations
13 papers, 348 citations indexed

About

Andrzej Dymek is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Otorhinolaryngology. According to data from OpenAlex, Andrzej Dymek has authored 13 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 4 papers in Otorhinolaryngology. Recurrent topics in Andrzej Dymek's work include Respiratory and Cough-Related Research (7 papers), Asthma and respiratory diseases (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Andrzej Dymek is often cited by papers focused on Respiratory and Cough-Related Research (7 papers), Asthma and respiratory diseases (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Andrzej Dymek collaborates with scholars based in Poland, United Kingdom and United States. Andrzej Dymek's co-authors include P. Le Roux, Hans Bisgaard, Christer Hultquist, Jan Vermeulen, Heikki Mansikka, Anna Bodzenta­‐Łukaszyk, Dragoș Bumbăcea, Grażyna Pulka, Tammy McIver and Cindy Garris and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Thorax.

In The Last Decade

Andrzej Dymek

10 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrzej Dymek Poland 6 310 303 34 19 19 13 348
J Małolepszy Poland 6 374 1.2× 349 1.2× 7 0.2× 13 0.7× 13 0.7× 10 452
Christer Hultquist Sweden 11 527 1.7× 510 1.7× 48 1.4× 10 0.5× 41 2.2× 12 581
J.M. Kouwenberg Netherlands 11 229 0.7× 260 0.9× 17 0.5× 15 0.8× 10 0.5× 15 329
Claire Houghton New Zealand 5 275 0.9× 254 0.8× 15 0.4× 12 0.6× 7 0.4× 8 311
Tito Atienza Sweden 5 566 1.8× 544 1.8× 23 0.7× 13 0.7× 17 0.9× 5 583
Richard Forth United Kingdom 11 411 1.3× 395 1.3× 14 0.4× 10 0.5× 23 1.2× 24 447
Eddie McKnight United Kingdom 7 210 0.7× 264 0.9× 9 0.3× 5 0.3× 2 0.1× 14 299
Moira H. Thomson United Kingdom 7 463 1.5× 540 1.8× 12 0.4× 17 0.9× 11 0.6× 9 593
Ola Beckman Sweden 9 338 1.1× 408 1.3× 12 0.4× 140 7.4× 8 0.4× 14 504
Nancy L. Hordvik United States 10 176 0.6× 268 0.9× 9 0.3× 12 0.6× 18 0.9× 10 306

Countries citing papers authored by Andrzej Dymek

Since Specialization
Citations

This map shows the geographic impact of Andrzej Dymek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Dymek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Dymek more than expected).

Fields of papers citing papers by Andrzej Dymek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Dymek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Dymek. The network helps show where Andrzej Dymek may publish in the future.

Co-authorship network of co-authors of Andrzej Dymek

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Dymek. A scholar is included among the top collaborators of Andrzej Dymek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Dymek. Andrzej Dymek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Han, Joseph, Piotr H. Skarżyński, Tanya M. Laidlaw, et al.. (2026). Efficacy and Safety of Verekitug (UPB-101) in Chronic Rhinosinusitis With Nasal Polyps: Results of the Phase 2 VIBRANT Trial. Journal of Allergy and Clinical Immunology. 157(2). AB432–AB432.
2.
Kukwa, Andrzej, et al.. (2013). A new approach to studying the nasal and oral breathing routes. Otolaryngologia Polska. 68(3). 112–118. 3 indexed citations
3.
Dymek, Andrzej, et al.. (2012). Refluks krtaniowo-gardłowy (LPR) u pacjentów z przewlekłą chrypką. Otolaryngologia Polska. 66(1). 33–38. 11 indexed citations
4.
Keith, Paul K., Andrzej Dymek, Oliver Pfaar, et al.. (2012). Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study. Primary Care Respiratory Journal. 21(3). 267–275. 15 indexed citations
6.
Bodzenta­‐Łukaszyk, Anna, Grażyna Pulka, Andrzej Dymek, et al.. (2011). Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler. Respiratory Medicine. 105(5). 674–682. 55 indexed citations
7.
Keith, Paul K., Andrzej Dymek, Oliver Pfaar, et al.. (2011). Efficacy and safety of fluticasone furoate nasal spray in adult and adolescent subjects with uncomplicated acute rhinosinusitis. Allergy Asthma and Clinical Immunology. 7(S2).
8.
Bodzenta­‐Łukaszyk, Anna, Andrzej Dymek, & Heikki Mansikka. (2010). P177 Fluticasone propionate/formoterol fumarate combination therapy is as effective as fluticasone propionate/salmeterol xinafoate in the treatment of asthma: a randomised controlled trial. Thorax. 65(Suppl 4). A152–A153. 1 indexed citations
11.
Bisgaard, Hans, et al.. (2006). Budesonide/Formoterol Maintenance Plus Reliever Therapy. CHEST Journal. 130(6). 1733–1743. 192 indexed citations
12.
Dymek, Andrzej, et al.. (2004). The presence of specific IgE to formaldehyde in patients with suspicion of hypersensitivity to this agent. Journal of Allergy and Clinical Immunology. 113(2). S224–S224.
13.
Dymek, Andrzej, et al.. (1995). Malignant melanoma of the larynx.. PubMed. 46(4). 255–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026